| Trial ID: | L5878 |
| Source ID: | NCT01215331
|
| Associated Drug: |
Insulin
|
| Title: |
Gestational Diabetes: Insulin or Oral Hypoglycemic Agents?
|
| Acronym: |
DG5
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Gestational Diabetes Mellitus
|
| Interventions: |
DRUG: Insulin|DRUG: Metformin, glyburide and insulin
|
| Outcome Measures: |
Primary: Glycemic control, Mean of the capillary glycemic control at 36 and 37th week of gestation., 36 and 37th week of gestation | Secondary: Acceptability of the treatment, 8-12 weeks after delivery
|
| Sponsor/Collaborators: |
Sponsor: Université de Sherbrooke | Collaborators: Fonds de la Recherche en Santé du Québec
|
| Gender: |
FEMALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
73
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-08
|
| Completion Date: |
2016-05
|
| Results First Posted: |
|
| Last Update Posted: |
2018-05-03
|
| Locations: |
Centre de recherche clinique du CHUS, Sherbrooke, Quebec, J1H 5N4, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT01215331
|
